Topical Antibiotics in Chronic Rhinosinusitis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

September 26, 2018

Primary Completion Date

February 1, 2021

Study Completion Date

February 1, 2021

Conditions
Chronic Rhinosinusitis (Diagnosis)
Interventions
DRUG

Mupirocin

30mg capsules dissolved in a standard 240mL saline irrigation rinse and self-administered through nasal saline irrigation twice per day over 30 days.

DRUG

Tobramycin

240mg capsules dissolved in a standard 240mL saline irrigation rinse and self-administered through nasal saline irrigation twice per day over 30 days.

DRUG

Levofloxacin

240mg capsules dissolved in a standard 240mL saline irrigation rinse and self-administered through nasal saline irrigation twice per day over 30 days.

DRUG

Vancomycin

240mg capsules dissolved in a standard 240mL saline irrigation rinse and self-administered through nasal saline irrigation twice per day over 30 days.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT03673956 - Topical Antibiotics in Chronic Rhinosinusitis | Biotech Hunter | Biotech Hunter